These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23769790)

  • 1. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
    Yang HS; Park SH
    Can J Ophthalmol; 2013 Jun; 48(3):e42-3. PubMed ID: 23769790
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab.
    Barkmeier AJ; Kadikoy H; Holz ER; Carvounis PE
    Eur J Ophthalmol; 2011; 21(4):506-8. PubMed ID: 21240857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
    Hwang H; Kim JY; Kim KT; Chae JB; Kim DY
    Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.
    Pikkel J; Rumelt S
    Eur J Ophthalmol; 2012; 22(3):488-91. PubMed ID: 21928270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Nowroozzadeh MH
    Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Chhablani JK; Narayanan R
    Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Lim SJ; Roh MI; Kwon OW
    Retina; 2010 Jan; 30(1):100-6. PubMed ID: 20010322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
    Okamoto M; Matsuura T; Ogata N
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):25-32. PubMed ID: 25559505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy.
    Lee JY; Chae JB; Yang SJ; Kim JG; Yoon YH
    Acta Ophthalmol; 2011 May; 89(3):e293-4. PubMed ID: 20346078
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy.
    Inoue M; Kadonosono K; Watanabe Y; Kobayashi S; Yamane S; Arakawa A
    Ophthalmologica; 2011; 225(1):37-40. PubMed ID: 20693820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
    Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
    Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
    Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
    Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.
    Schaal KB; Hoeh AE; Scheuerle A; Schuett F; Dithmar S
    Eur J Ophthalmol; 2009; 19(4):613-7. PubMed ID: 19551677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.
    Kim GA; Rim TH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS
    Eye (Lond); 2015 Jun; 29(6):732-40; quiz 741. PubMed ID: 25952951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
    Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
    Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy.
    Nomura Y; Obata R; Yanagi Y
    Jpn J Ophthalmol; 2012 May; 56(3):245-9. PubMed ID: 22526618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.
    Broadhead GK; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):979-81. PubMed ID: 25547617
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.
    Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H
    Curr Eye Res; 2010 Feb; 35(2):91-8. PubMed ID: 20136418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroidal detachment after PASCAL photocoagulation.
    Natesh S; Ranganath A; Harsha K; Yadav NK; Bhujang BS
    Can J Ophthalmol; 2011 Feb; 46(1):91. PubMed ID: 21283169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.